291 related articles for article (PubMed ID: 1968292)
1. Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.
Badenhoop K; Schwarz G; Bingley P; Lewis V; Drummond V; Gale EA; Bottazzo GF
Tissue Antigens; 1990 Jan; 35(1):32-9. PubMed ID: 1968292
[TBL] [Abstract][Full Text] [Related]
2. Restriction fragment length polymorphism of HLA and non-HLA genes in DR3/4 heterozygous Danish insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of alpha DX and insulin-linked polymorphic loci, and new splits of DQw3 haplotypes.
Zerbib A; Mølvig J; Thomsen M; Coppin H; Cambon-Thomsen A; Sommer E; Nerup J; De Preval C
Dis Markers; 1989; 7(1):27-41. PubMed ID: 2565778
[TBL] [Abstract][Full Text] [Related]
3. HLA DR4-DQw3.1 and 3.2 haplotypes among insulin-dependent diabetics and their unaffected sibs in the GAW5 data.
Gogolin KJ; Spielman RS
Genet Epidemiol; 1989; 6(1):113-6. PubMed ID: 2567253
[TBL] [Abstract][Full Text] [Related]
4. HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation.
Monos DS; Spielman RS; Gogolin KJ; Radka SF; Baker L; Zmijewski CM; Kamoun M
Immunogenetics; 1987; 26(4-5):299-303. PubMed ID: 2888728
[No Abstract] [Full Text] [Related]
5. HLA class II (DR, DQ) in Japanese patients with type 1 diabetes mellitus.
Tanaka M; Abe J; Ito J; Horikawa R; Miki Y; Nakayama M; Kohsaka T; Tanae A; Hibi I
Acta Paediatr Jpn; 1990 Dec; 32(6):645-50. PubMed ID: 1982037
[TBL] [Abstract][Full Text] [Related]
6. A deletion mutant defines DQ beta variants with DR4 positive DQw3 positive haplotypes.
Nepom BS; Kim SJ; Nepom GT
Hum Immunol; 1986 Oct; 17(2):87-93. PubMed ID: 2875977
[TBL] [Abstract][Full Text] [Related]
7. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships.
Carrier CM; Mollen N; Rothman WC; Rodriguez de Cordoba S; Rey-Campos J; Ginsberg-Fellner F; Carpenter C; Rubinstein P
Hum Immunol; 1989 Jan; 24(1):51-63. PubMed ID: 2563360
[TBL] [Abstract][Full Text] [Related]
8. Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus.
Monos DS; Mickelson E; Hansen JA; Baker L; Zmijewski CM; Kamoun M
Hum Immunol; 1988 Dec; 23(4):289-99. PubMed ID: 3266208
[TBL] [Abstract][Full Text] [Related]
9. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
[TBL] [Abstract][Full Text] [Related]
10. New HLA DNA polymorphisms associated with rheumatoid arthritis.
Cutbush SD; Ollier W; Awad J; Currey HL; Festenstein H
Dis Markers; 1986 Jun; 4(1-2):173-83. PubMed ID: 2898314
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of DQ beta genes in HLA-DR4 haplotypes from healthy and diabetic individuals.
Henson V; Maclaren N; Riley W; Wakeland EK
Immunogenetics; 1987; 25(3):152-60. PubMed ID: 2881884
[TBL] [Abstract][Full Text] [Related]
12. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
Robinson DM; Holbeck S; Palmer J; Nepom GT
Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of HLA genetic factors in IDDM susceptibility.
Martell M; Marcadet A; Moine A; Boitard C; Deschamps I; Dausset J; Bach JF; Cohen D
Immunogenetics; 1990; 31(4):233-40. PubMed ID: 1970333
[TBL] [Abstract][Full Text] [Related]
14. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
[TBL] [Abstract][Full Text] [Related]
15. DQ beta restriction fragment length polymorphism and its relationship to insulin dependent diabetes mellitus.
Sachs JA; Cassell PG; Festenstein H; Awad J; Hitman GA
Dis Markers; 1987 Dec; 5(4):199-206. PubMed ID: 2901934
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetic markers for autoimmune diseases of the endocrine system.
Badenhoop K
Klin Wochenschr; 1990; 68 Suppl 21():10-4. PubMed ID: 1973965
[TBL] [Abstract][Full Text] [Related]
17. HLA-DQ heterogeneity among HLA-DRw11(5) haplotypes.
Amar A; Mickelson E; Hansen JA; Nepom GT
Tissue Antigens; 1986 Nov; 28(5):278-87. PubMed ID: 2881380
[TBL] [Abstract][Full Text] [Related]
18. Extended HLA haplotypes in multiplex families with insulin dependent diabetes mellitus in Tunisian population: HLA serological typing and RFLP analysis.
Jenhani F; Bardi R; Ayed K; Chammakhi S; Jeddi M; Labonne MP; Gebuhrer L; Betuel H
Dis Markers; 1990; 8(6):327-31. PubMed ID: 1983195
[TBL] [Abstract][Full Text] [Related]
19. The HLA-DR4-associated DQw8 allele is confined to HLA-DR3/DR4 heterozygous type I (insulin-dependent) diabetics.
Boehm BO; Schifferdecker E; Rosak C; Kuehnl P; Driesel AJ; Schöffling K
Tissue Antigens; 1990 Aug; 36(2):81-2. PubMed ID: 1980162
[TBL] [Abstract][Full Text] [Related]
20. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
